Page last updated: 2024-11-12

pyridine triphenylborane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyridine triphenylborane: an antifouling biocide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10925275
SCHEMBL ID394177
MeSH IDM0580873

Synonyms (10)

Synonym
AKOS015840382
A845690
pyridine-triphenylborane
pyridine; triphenylborane
SCHEMBL394177
DTXSID20448581
pyridine triphenylborane
pyridine;triphenylborane
boron, triphenyl(pyridine)-, (t-4)-
P2785

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" DPB was the most toxic of the degradation products to all four organisms."( Toxicity of degradation products of the antifouling biocide pyridine triphenylborane to marine organisms.
Fujii, K; Ito, K; Ito, M; Mochida, K; Ojima, D; Onduka, T, 2013
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]